Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Got arthritis? DNAlytics has an app for it!

Approximately 30% of patients with undifferentiated arthritis develop rheumatoid arthritis - a chronic, inflammatory disease causing deformity of …


MiDiagnostics develops disposable chip for blood self-testing

MiDiagnostics is a new startup that will make disposable chips to test your own blood and saliva. Only 15 minutes after the test, you will be able…


More efficient aerosol therapy

Aerosol therapy is an important aspect of respiratory care. The drug-delivery efficiency depends on the deposition of the aerosol particles in the…

POPULAR TAGS

Novosanis supplies urine collection device to MDxHealth

Written by DS on in the category news with the tags .


Novosanis today announced that it signed an agreement with MDxHealth to supply UrNCollect™, a customized version of the Company’s patented urine collection device called Colli-Pee™. The medical device facilitates accurate sample collection for urine-based tests.

You might also be interested in 'Urine HPV screening'

The privately-owned medical device company, Novosanis, and MDxHealth SA (Euronext: MDXH.BR) signed a supply agreement for a customized version of Novosanis’ first void urine collection device, Colli-Pee™. The device allows for a standardized, hygienic and user-friendly collection of the first 20ml of the urine stream and reduces lab errors by automating preservative mixing without additional handling.

“We are happy to initiate a collaboration with MDxHealth. Our Colli-Pee device will allow easy collection of standardized first void urine with less handling and no traditional pipetting. Everybody gains when the sample collection process is simplified and streamlined.” said Dr. Vanessa Vankerckhoven, CEO and co-founder of Novosanis.

Dr. Jan Groen, CEO MDxHealth, commented: “MDxHealth is pleased with Novosanis’ development of UrNCollectTM for our SelectMDx for Prostate Cancer IVD kit that will launch later this year. We expect the device to be more comfortable for patients and contribute to the test’s accuracy.”

Read more about: .

RELATED ARTICLES
Got arthritis? DNAlytics has an app for it!

Approximately 30% of patients with undifferentiated arthritis develop rheumatoid arthritis - a chronic, inflammatory disease causing deformity of …


MiDiagnostics develops disposable chip for blood self-testing

MiDiagnostics is a new startup that will make disposable chips to test your own blood and saliva. Only 15 minutes after the test, you will be able…


More efficient aerosol therapy

Aerosol therapy is an important aspect of respiratory care. The drug-delivery efficiency depends on the deposition of the aerosol particles in the…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Itera Life Science Flanders.bio Turnstone XpandInnovation UGent KU Leuven V-Bio Ventures Biowin GSK Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.